Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Prostate Cancer

TON - September 2013 Vol 6 No 8 published on September 23, 2013 in Noteworthy Numbers, Hematologic Cancers
Wayne Kuznar

As the second leading cause of cancer-related deaths among men in the United States, prostate cancer is expected to cause approximately 29,720 deaths during 2013.1 In recognition of National Prostate Cancer Awareness Month, let’s examine these prostate cancer statistics.

According to the Prostate Cancer Foundation, the average age at the time of prostate cancer diagnosis is 69 years. Moreover, 1
in 14 men between the ages of 60 and 69 years receive a prostate cancer diagnosis.2

Prostate cancer is less common in men younger than 40 years, with 1 in 10,000 men affected.2

Overall, approximately 238,590 men in the US will be diagnosed with prostate cancer in 2013.1

The American Cancer Society states that the ratio of men who will die from prostate cancer is 1:36.1

African American men in the US are almost 2.5 times as likely to die from prostate cancer as white men.3 The rate of prostate cancer is less in Asian American and Hispanic men than in non-Hispanic white men. The reasons behind these racial and ethnic differences are unclear.4

Compared with men in the US whose risk for prostate cancer is 17%, men who live in rural China have less risk (2%) of developing prostate cancer. Yet, the risk for prostate cancer increases for Chinese men if they move to a more western-style culture, reports the Prostate Cancer Foundation.2

According to the World Cancer Research Fund International, about 7 in 10 prostate cancer cases (72%) occur in more developed countries, with the highest rates of diagnosis in Australia and New Zealand, Western Europe, and North America.5

Sources
1. http://www.cancer.org/cancer/prostatecancer/detailed guide/prostate-cancer-key-statistics.
2. http://www.pcf.org/site/c.leJRIROrEpH/b.5802027/k.D271/Prostate_Cancer_Risk_Factors.htm.
3. http://www.pcf.org/site/c.leJRIROrEpH/b.8481037/k.1EF4/AfricanAmerican_Men__Risk_Factors.htm.
4. http://www.cancer.org/cancer/prostatecancer/detailed guide/prostate-cancer-risk-factors.
5. http://www.wcrf.org/cancer_statistics/data_specific_cancers/prostate_cancer_statistics.php.

Related Items
Noteworthy Numbers: Ovarian Cancer
TON - October 2019, Vol 12, No 5 published on October 7, 2019 in Noteworthy Numbers
Noteworthy Numbers: Bone Cancer
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in Noteworthy Numbers
Assessment of Opioid Misuse and Abuse Should Be Part of Cancer Pain Management
Wayne Kuznar
TON - June 2019, Vol 12, No 3 published on June 17, 2019 in Pain Management, NCCN
First Positive Showing for Mesothelin-Directed CAR T-Cell Therapy in Solid Tumors
Wayne Kuznar
TON - June 2019, Vol 12, No 3 published on June 17, 2019 in Immunotherapy
Luspatercept, First-in-Class Erythroid Maturation Agent, Reduces Transfusions in Patients with Low-Risk MDS
Wayne Kuznar
TON - April 2019, Vol 12, No 2 published on April 22, 2019
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Wayne Kuznar
TON - February 2019, Vol 12, No 1 published on March 1, 2019 in Colorectal Cancer
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
TON - February 2019, Vol 12, No 1 published on March 1, 2019 in Leukemia
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
TON - November 2018, Vol 11, No 5 published on November 28, 2018 in Immunotherapy
Noteworthy Numbers: Ovarian Cancer
TON - September 2018, Vol 11, No 4 published on September 19, 2018 in Noteworthy Numbers
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
Wayne Kuznar
TON - September 2018, Vol 11, No 4 published on September 19, 2018 in Lynch Syndrome
Last modified: September 9, 2019